In experimental models of stroke, inflammation appears to contribute to cer
ebral ischemic injury. Clinical trials that are aimed at limiting the posti
schemic inflammatory response, however, have thus far had disappointing res
ults. These clinical failures probably reflect the fact that there has been
insufficient preclinical data and inadequate trial design, rather than pro
vide evidence against a role for inflammation in ischemic brain injury. Cur
r Opin Neurol 14:349-353. (C) 2001 Lippincott Williams & Wilkins.